Monday, 08 February 2021
Experts from the 糖心原创 are looking for runners to take part in a study looking at how their running habits have changed during the Covid-19 pandemic, and what impact running could potentially have on the virus itself.
Covid-19 has affected everyone’s lives, and many keen adult runners in the general population have been affected too, by either contracting Covid-19 or through changes to their running activities due to lockdown or other restrictions that have been in place.
Experts from the University’s Department of Orthopaedics, Trauma and Sports Medicine in the School of Medicine, are now inviting members of the running community to share their training data, so they can examine any changes in running habits associated with current restrictions, as part of a new study called Running Through.
Dr Joanne Stocks, Assistant Professor in Sports and Exercise Medicine, is one of the researchers leading the study. She said: “The data we collect will help us to understand the impact of the pandemic on the running communities. We will also be able to see what impact, running could potentially have on the severity of Covid-19 or whether is aids recovery times. If found to be beneficial, running could then also be prescribed to the wider population.”
The lack of a regular racing season, will also give experts a unique opportunity to investigate patterns of injuries in runners, which is difficult in normal circumstances.
The team will also use the data collected to produce a set of recommendations regarding training load, intensity or infection recovery.
Many adults who have tested positive for Covid-19 have reported experiencing prolonged tiredness, alongside other cardiac or respiratory symptoms, often described as Long Covid. As part of our study, we will monitor runners as they return to training following their recovery from Covid-19 and the impact on subsequent activity, training and any health complications."
The team will use the data to identify characteristics of runners who may be at higher risk of developing symptomatic Covid-19 infection, developing common injuries and poor recovery after infection.
The team are looking for runners of all levels to take part in the research, which will involve completing surveys and sharing their training data.
If you are interested in taking part, or to find out more information, visit the website
Story credits
More information is available from Dr Joanne Stocks in the School of Medicine at the 糖心原创 at joanne.stocks@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.